Vaccinations in children with cancer

Vaccine

Volumn 28, Issue 19, 2010, Pages 3278-3284

  Esposito, Susanna ^a   Cecinati, Valerio ^b   Brescia, Letizia ^b   Principi, Nicola ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF BARI   (Italy)

Author keywords

Cancer; Children; Prevention; Vaccination; Vaccines

Indexed keywords

CYCLOPHOSPHAMIDE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; FLUDARABINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS A VACCINE; HEPATITIS B VACCINE; INACTIVATED VACCINE; INFLUENZA VACCINE; LIVE VACCINE; MEASLES MUMPS RUBELLA VACCINE; MENINGOCOCCUS VACCINE; MERCAPTOPURINE; PNEUMOCOCCUS VACCINE; POLIOMYELITIS VACCINE; RECOMBINANT VACCINE; STEROID; VARICELLA ZOSTER VACCINE;

CANCER CHEMOTHERAPY; CANCER PREVENTION; CANCER RISK; CHILDHOOD CANCER; DIPHTHERIA; DRUG EFFICACY; DRUG RESEARCH; DRUG SAFETY; DRUG TOLERABILITY; EVIDENCE BASED MEDICINE; HAEMOPHILUS INFECTION; HEPATITIS A; HEPATITIS B; HERPES ZOSTER; HUMAN; HUMORAL IMMUNITY; IMMUNE SYSTEM; IMMUNOCOMPROMISED PATIENT; IMMUNOGENICITY; INFLUENZA; LEUKEMIA; MEASLES; MENINGOCOCCOSIS; MUMPS; PEDIATRICIAN; PEDIATRICS; PERTUSSIS; PNEUMOCOCCAL INFECTION; POLIOMYELITIS; PRIORITY JOURNAL; REVIEW; RUBELLA; TETANUS; VACCINATION;

BACTERIAL VACCINES; CHILD; HUMANS; IMMUNOCOMPROMISED HOST; NEOPLASMS; VACCINATION; VIRAL VACCINES;

EID: 77950492235     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.02.096     Document Type: Review

References (78)

1. Mackall C.L. T-cell immunodeficiency following antineoplastic therapy: a review. Stem Cells 18 (2000) 10-18
2. Adamson P.C., Balis F.M., and Berg S. General principles of chemotherapy. In: Pizzo D.A., and Poplack D.G. (Eds). Principles and practices of pediatric oncology. 5th edition (2006), Lippincott Williams & Wilkins, Philadelphia 290-365
3. van Tilburg C.M., Sanders E.A.M., Rovers M.M., Wolfs T.F., and Bierings M.B. Loss of antibodies and response to (re-)vaccination in children after treatment for acute lymphocytic leukemia: a systematic review. Leukemia 20 (2006) 1717-1722
4. Storek J., Gedde M., Khan F., Huard B., Helg C., Chalandon Y., et al. Reconstitution of the immune system after hematopoietic stem cell transplantation in humans. Semin Immunopathol 30 (2008) 425-437
5. Ljungman P., Cordonnier C., de Block R., Einsele H., Engelhard D., Grundy J., et al. Immunization after bone marrow transplantation: results of a European survey and recommendations from the infectious diseases working party of the European Group for Blood and Marrow Bone Transplantation. Bone Marrow Transplant 15 (1995) 455-460
6. Mustafa M.M., Buchanan G.R., Winick N.J., McCracken G.H., Tkaczewski I., Lipscomb M., et al. Immune recovery in children with malignancy after cessation of chemotherapy. J Pediatr Hematol Oncol 20 (1998) 451-457
7. Fioredda F., Cavillo M., Banov L., Plebani A., Timitilli A., and Castagnola E. Immunization after elective end of antineoplastic chemotherapy in children. Pediatr Blood Cancer 52 (2009) 165-168
8. de Vaan G.A.M., van Munster P.J.J., and Bakkeren J.A.J.M. Recovery of immune function after cessation of maintenance therapy in acute lymphoblastic leukemia of childhood. Eur J Pediatr 132 (1982) 113-117
9. Reinhardt D., Houliara K., Pekrun A., Lakomek M., and Krone B. Impact of conventional chemotherapy on levels of antibodies against vaccine preventable disease in children treated for cancer. Scand J Infect Dis 35 (2003) 851-857
10. Zignol M., Peracchi M., Tridello G., Pillon M., Fregonese F., D'Elia R., et al. Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapy. Cancer 101 (2004) 635-641
11. Ercan T.E., Soycan L.Y., Apak H., Celkan T., Ozkan A., Akdenizli E., et al. Antibody titers and immune response to diphtheria-tetanus-pertussis and measles-mumps-rubella vaccination in children treated for acute lymphoblastic leukemia. J Pediatr Hematol Oncol 27 (2005) 273-277
12. Hersh E.M., Whitecar Jr. J.P., McCredie K.B., Bodey Sr. G.P., and Freireich E.J. Chemotherapy, immunocompetence, immunosuppression and prognosis in acute leukemia. N Engl J Med 285 (1971) 1211-1216
13. Fuks Z., Strober S., Bobrove A.M., Sasazuki T., McMichael A., and Kaplan H.S. Long term effects of radiation on T and B lymphocytes in the peripheral blood of patients with Hodgkin's disease. J Clin Invest 58 (1976) 803-814
14. Magrath I.T., and Simon R.M. Immunosuppression in Burkitt's lymphoma. II. Peripheral blood lymphocyte populations related to clinical status. Int J Cancer 18 (1976) 399-408
15. Mackall C.L., Fleisher T.A., Brown M.R., Magrath I.T., Shad A.T., Horowitz M.E., et al. Lymphocyte depletion during treatment with intensive chemotherapy for cancer. Blood 84 (1994) 2221-2228
16. Komada Y., Zhang S.L., Zhou Y.W., Hanada M., Shibata T., Azuma E., et al. Cellular immunosuppression in children with acute lymphoblastic leukemia: effect of consolidation chemotherapy. Cancer Immunol Immunother 35 (1992) 271-276
17. Hakim F.T., Cepeda R., Kaimei S., Mackall C.L., McAtee N., Zujewski J., et al. Constraints on CD4 recovery post chemotherapy in adults: thymic insufficiency and apoptotic decline of expanded peripheral CD4 cells. Blood 90 (1997) 3789-3798
18. Nilsson A., De Milito A., Engström P., Nordin M., Narita M., Grillner L., et al. Current chemotherapy protocols for childhood acute lymphoblastic leukemia induce loss of humoral immunity to viral vaccination antigens. Pediatrics 109 (2002) e91-e96
19. Torben E.K., Mellander L., Andersson B., and Abrahamsson J. Immune reconstitution after childhood lymphoblastic leukemia is most severely affected in high risk group. Pediatric Blood Cancer 44 (2005) 461-468
20. Kosmidis S., Baka M., Bouhoutsou D., Doganis D., Kallergi C., Douladiris N., et al. Longitudinal assessment of immunological status and rate of immune recovery following treatment in children with ALL. Pediatr Blood Cancer 50 (2008) 528-532
21. Brodtman D.H., Rosenthal D.W., Redner A., Lanzkowsky P., and Bonagura V.R. Immunodeficiency in children with acute lymphoblastic leukemia after completion of modern aggressive chemotherapeutic regimens. J Pediatr 146 (2005) 654-661
22. van der Does-van der Berg A., Hermans J., Nagel J., and van Steenis G. Immunity to diphtheria pertussis tetanus, and poliomyelitis in children with acute lymphocytic leukemia after cessation of chemotherapy. Pediatrics 67 (1981) 222-229
23. Feldman S., Andrew M., Norris M., McIntyre B., and Iyer R. Decline in rates of seropositivity for measles, mumps, and rubella antibodies among previously immunized children treated for acute leukemia. Clin Infect Dis 27 (1998) 388-390
24. Patel S.R., Ortin M., Cohen B.J., Borrow R., Irving D., Sheldon J., et al. Revaccination of children after completion of standard chemotherapy for acute leukemia. Clin Infect Dis 44 (2007) 635-642
25. Mackall C.L., Fleisher T.A., Brown M.R., Andrich M.P., Chen C.C., Feuerstein I.M., et al. Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy. N Engl J Med 332 (1995) 143-149
26. Mackall C.L., Fleisher T.A., Brown M.R., Andrich M.P., Chen C.C., Feuerstein I.M., et al. Distinctions between CD8+ and CD4+ T-cell regeneration pathways result in prolonged T-cell subset imbalance after intensive chemotherapy. Blood 89 (1997) 3700-3707
27. Luthy K.E., Tiedeman Me, Beckstrand R.L., and Mills D.A. Safety of live-virus vaccines for children with immune deficiency. J Am Acad Nurse Pract 18 (2006) 494-503
28. Poulsen A., Schmiegelow K., and Yssing M. Varicella zoster infections in children with acute lymphoblastic leukemia. Pediatr Hematol Oncol 13 (1996) 231-238
29. Clements D.A. Varicella vaccination in children. BioDrugs 14 (2000) 49-60
30. Adler A.L., Casper C., Boeckh M., Heath J., and Zerr D.M. An outbreak of varicella with likely breakthrough disease in a population of pediatric cancer patients. Infect Control Hosp Epidemiol 29 (2008) 866-870
31. Levin M.J. Varicella vaccination of immunocompromised children. J Infect Dis 197 (2008) S200-S206
32. Gershon A.A., Steinberg S.P., and Gelb L. Live attenuated varicella vaccine use in immunocompromised children and adults. Pediatrics 78 (1986) 757-762
33. Gershon A.A., Steinberg S.P., Gelb L., Galasso G., Borkowsky W., LaRussa P., et al. Live attenuated varicella vaccine. Efficacy for children with leukemia in remission. JAMA 252 (1984) 355-362
34. Gershon A.A., and Steinberg S.P. Persistence of immunity to varicella in children with leukemia immunized with live attenuated varicella vaccine. N Engl J Med 320 (1989) 892-897
35. Ninane J., Latinne D., Heremans-Bracke M.T., De Bruyere M., and Comu G. Live varicella vaccine in severely immunodepressed children. Postgrad Med J 61 Suppl 4 (1985) 97-102
36. Excevit Z., Büyükpamukçu, Kanra G., Sevinir B., and Ueda S. Oka strain live varicella vaccine in children with cancer. Pediatr Infect Dis J 15 (1996) 169-170
37. Gershon A.A., LaRussa P., and Steinberg S. The varicella vaccine. Clinical trials in immunocompromised individuals. Infect Dis Clin North Am 10 (1996) 583-594
38. Kung F.H., Orgel H.A., Wallace W.W., and Hamburger R.N. Antibody protection following immunization with diphtheria and tetanus toxoids in children receiving chemotherapy during remission of malignant disease. Pediatrics 74 (1984) 86-89
39. Ridgway D., Wolff L.J., and Deforest A. Immunization response varies with intensity of acute lymphoblastic leukemia therapy. Am J Dis Child 145 (1991) 887-891
40. Zengin E., and Sarper N. Humoral immunity to diphtheria, tetanus, measles, and haemophilus influenzae type b in children with acute lymphoblastic leukemia and response to re-vaccination. Pediatr Blood Cancer 53 (2009) 967-972
41. Esposito S., Agliardi T., Giammanco A., Faldella G., Cascio A., Bosis S., et al. Long-term pertussis-specific immunity after a primary vaccination with a combined diphtheria, tetanus, tricomponent acellular pertussis and hepatitis B vaccine in comparison with natural infection. Infect Immun 69 (2001) 4516-4520
42. Esposito S., Faldella G., Giammanco A., Bosis S., Friscia O., Clerici M., et al. Long-term pertussis-specific immune responses to a combined diphtheria, tetanus, tricomponent acellular pertussis and hepatitis B vaccine in pre-term infants. Vaccine 20 (2002) 2928-2932
43. Stenvik M., Hovi L., Siimes M.A., Roivainen M., and Hovi T. Antipolio prophylaxis of immunocompromised children during a nationwide oral poliovaccine campaign. Pediatr Infect Dis J 6 (1987) 1106-1110
44. Rolston K.V. The spectrum of pulmonary infections in cancer patients. Curr Opin Oncol 13 (2001) 218-223
45. Lee A.C., and Lam S.Y. Life threatening acute epiglottitis in acute leukemia. Leuk Lymphoma 43 (2002) 665-667
46. Shenep J.L., Feldman S., Gigliotti F., Roberson P.K., Marina N., Foreschle J.E., et al. Response of immunocompromised children with solid tumors to a conjugate vaccine for Haemophilus influenzae type b. J Pediatr 125 (1994) 581-584
47. Groves F.D., Sinha D., Kayhty H., Goedert J.J., and Levine P.H. Haemophilus influenzae type b serology in childhood leukaemia: a case-control study. Br J Cancer 85 (2001) 337-340
48. Sinsalo M., Aittoniemi J., Käyhty H., and Vilpo J. Haemophilus influenzae type b (Hib) antibody concentrations and vaccination responses in patients with chronic lymphocytic leukemia: predicting factors for response. Leuk Lymphoma 43 (2002) 1967-1979
49. EK T., Mellander L., Hahn-Zoric M., and Abrahamsson J. Intensive treatment for childhood acute lymphoblastic leukemia reduces immune response to diphtheria, tetanus and Haemophilus influenzae type b. J Pediatr Hematol Oncol 26 (2004) 727-734
50. EK T., Mellander L., Hahn-Zoric M., and Abrahamsson J. Avidity of tetanus and Hib antibodies after childhood acute lymphoblastic leukemia. Implications for vaccinations strategy. Acta Paediatr 95 (2006) 701-706
51. Debbache K., Varon E., Hicheri Y., Legrand P., Donay J.L., Ribaud P., et al. The epidemiology of invasive Streptococcus pneumoniae infections in oncohaematology and haematopoietic stem cell transplant patients in France. Are the serotypes covered by the available anti-pneumococcal vaccines?. Clin Microbiol Infect 15 (2009) 865-868
52. O'Brien K.L., Hochman M., and Goldblatt D. Combined schedules of pneumococcal conjugate and polysaccharide vaccines: is hyporesponsiveness an issue?. Lancet Infect Dis 7 (2007) 597-606
53. Chan C.Y., Molrine D.C., George S., Tarbell N.J., Mauch P., Diller L., et al. Pneumococcal conjugate vaccine primes for antibody response to polysaccharide pneumoccacal vaccine after treatment of Hodgkin's disease. J Infect Dis 173 (1996) 256-258
54. Melcher L. Recommendations for influenza and pneumococcal vaccinations in people receiving chemotherapy. Clin Oncol (R Coll Radiol) 17 (2005) 12-15
55. Sinisalo M., Vilpo J., Itala M., Vakevainen M., Taurio J., and Aittoniemi J. Antibody response to 7-valent conjugated pneumococcal vaccine in patients with chronic lymphocytic leukaemia. Vaccine 26 (2007) 82-87
56. Yu J.W., Borkowski A., Danzig L., Reiter S., Kavan P., and Mazer B.D. Immune response to conjugate meningococcal C vaccine in pediatric oncologic patients. Pediatr Blood Cancer 49 (2007) 918-923
57. Principi N., and Esposito S. Are we ready for universal influenza vaccination in paediatrics?. Lancet Infect Dis 4 (2004) 75-83
58. Esposito S., Marchisio P., and Principi N. The global state of influenza in children. Pediatr Infect Dis J 27 11 Suppl. (2008) S149-S153
59. Fiore AE, Shay DK, Broder K, Iskander JK, Uyeki TM, Mootrey G, et al. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Recomm Rep 2009; 58(RR-8):1-52 [Erratum in: MMWR Recomm Rep. 2009 Aug 21;58(32):896-7].
60. Gross P.A., Lee H., Wolff J.A., Hall C.B., Minnefore A.B., and Lazicki M.E. Influenza immunization in immunosuppressed children. J Pediatr 92 (1978) 30-35
61. Lange B., Shapiro S.A., Waldman M.T., Proctor E., and Arbeter A. Antibody responses to influenza immunization of children with acute lymphoblastic leukemia. J Infect Dis 140 (1979) 402-406
62. Chisholm J.C., Devine T., Charlett A., Pinkerton C.R., and Zambon M. Response to influenza immunization during treatment for cancer. Arch Dis Child 84 (2001) 496-500
63. Hsieh Y.C., Lu M.Y., Kao C.L., Chiang B.L., Lin D.T., Lin K.S., et al. Response to influenza vaccine in children with leukemia undergoing chemotherapy. J Formos Med Assoc 101 (2002) 700-704
64. Porter C.C., Edwards K.M., Zhu Y., and Frangoul H. Immune responses to influenza immunization in children receiving maintenance chemotherapy for acute lymphoblastic leukemia. Pediatr Blood Cancer 42 (2004) 36-40
65. Chisholm J., Howe K., Taj M., and Zambon M. Influenza immunization in children with solid tumors. Eur J Cancer 41 (2005) 2280-2287
66. Matsuzaki A., Suminoe A., Koga Y., Kinukawa N., Kusuhara K., and Hara T. Immune response after influenza vaccination in children with cancer. Pediatr Blood Cancer 45 (2005) 831-837
67. Esposito S., Cecinati V., Russo F.G., and Principi N. Influenza vaccination in children with cancer receiving chemotherapy. Human Vaccin 5 (2009) 430-432
68. Cecinati V., Esposito S., Schicchitano B., Delvecchio G.C., Amato D., Pelucchi C., et al. Effectiveness of recall systems for improving influenza vaccination coverage in children with oncohematologic malignancies. Vaccine 28 (2010) 1558-1565
69. Goossen G.M., Kremer L.C.M., and van de Wetering M.D. Influenza vaccination in children being treated with chemotherapy for cancer. Cochrane Database Syst Rev 2 (2009) CD006484
70. Esposito S, Cecinati V, Scicchitano B, Delvecchio GC, Santoro N, Amato D, et al. Impact of influenza-like illness and effectiveness of influenza vaccination in oncohematological children who have completed cancer therapy. Vaccine 2009;Dec 8 Epub.
71. McFarlane E.S., and Embil J.A. Prevalence of antibodies to hepatitis A antigen in sera from patients with haematological malignancies. J Med Virol 8 (1981) 49-53
72. Bodey G.P., Bolivar R., and Fainstein V. Infectious complications in leukemic patients. Semin Hematol 19 (1982) 193-226
73. Takai S., Tsurumi H., Ando K., Kasahara S., Sawada M., Yamada T., et al. Prevalence of hepatitis B and C virus infection in haematological malignancies and liver injury following chemotherapy. Eur J Haematol 74 (2005) 158-165
74. Chen M.H., Hsiao L.T., Chiou T.J., Liu J.H., Gau J.P., Teng H.W., et al. High prevalence of occult hepatitis B virus infection in patients with B cell non-Hodgkin's lymphoma. Ann Hematol 87 (2008) 475-480
75. Köksal Y., Yalçin B., Aydin G.B., Sari N., Yazici N., Yalcin B., et al. Comparison of accelerated and rapid schedules for monovalent hepatitis B and combined hepatitis A/B vaccines in children with cancer. Pediatr Hematol Oncol 24 (2007) 587-594
76. Meral A., Sevinir B., and Günay U. Efficacy of immunization against hepatitis B virus infection in children with cancer. Med Pediatr Oncol 35 (2000) 47-51
77. Yetgin S., Tavil B., Aytac S., Kuskonmaz B., and Kanra G. Unexpected protection from infection by two booster hepatitis B vaccination in children with acute lymphoblastic leukemia. Leuk Res 31 (2007) 493-496
78. Baytan B., Gunes A.M., and Gunay U. Efficacy of primary hepatitis B immunization in children with acute lymphoblastic leukemia. Indian Pediatr 45 (2008) 265-270